Terms: = Ovarian cancer AND NFE2L2, ENSG00000116044, 4780, Q16236, NRF2 AND Prognosis
11 results:
1. UBE2E2 enhances Snail-mediated epithelial-mesenchymal transition and nrf2-mediated antioxidant activity in ovarian cancer.
Hong X; Ma N; Li D; Zhang M; Dong W; Huang J; Ci X; Zhang S
Cell Death Dis; 2023 Feb; 14(2):100. PubMed ID: 36765041
[TBL] [Abstract] [Full Text] [Related]
2. Fertility-Sparing Approach in Patients with Endometrioid Endometrial cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review.
Giampaolino P; Cafasso V; Boccia D; Ascione M; Mercorio A; Viciglione F; Palumbo M; Serafino P; Buonfantino C; De Angelis MC; Verrazzo P; Grasso G; Gullo G; Bifulco G; Della Corte L
Biomed Res Int; 2022; 2022():4070368. PubMed ID: 36203482
[TBL] [Abstract] [Full Text] [Related]
3. Prognostic Value and Immune Infiltration Analysis of Nuclear Factor Erythroid-2 Family Members in ovarian cancer.
Dou R; Wang X; Zhang J
Biomed Res Int; 2022; 2022():8672258. PubMed ID: 35059466
[TBL] [Abstract] [Full Text] [Related]
4. Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the nrf2 pathway.
Zhao F; Hong X; Li D; Wei Z; Ci X; Zhang S
Med Oncol; 2021 Apr; 38(5):54. PubMed ID: 33811596
[TBL] [Abstract] [Full Text] [Related]
5. Pan-cancer Multiomics Analysis of TC2N Gene Suggests its Important Role(s) in Tumourigenesis of Many cancers.
Qureshi MA; Khan S; Tauheed MS; Syed SA; Ujjan ID; Lail A; Sharafat S
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3199-3209. PubMed ID: 33247676
[TBL] [Abstract] [Full Text] [Related]
6. nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression.
Wu J; Zhang L; Li H; Wu S; Liu Z
Biochem Biophys Res Commun; 2019 Oct; 518(4):698-705. PubMed ID: 31472965
[TBL] [Abstract] [Full Text] [Related]
7. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
[TBL] [Abstract] [Full Text] [Related]
8. Expression Patterns of nrf2 and Keap1 in ovarian cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival.
Cho HY; Kim K; Kim YB; Kim H; No JH
Int J Gynecol Cancer; 2017 Mar; 27(3):412-419. PubMed ID: 28129239
[TBL] [Abstract] [Full Text] [Related]
9. BRCA1 deficiency increases the sensitivity of ovarian cancer cells to auranofin.
Oommen D; Yiannakis D; Jha AN
Mutat Res; 2016; 784-785():8-15. PubMed ID: 26731315
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic and predictive values of nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
[TBL] [Abstract] [Full Text] [Related]
11. cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.
Mizuno T; Suzuki N; Makino H; Furui T; Morii E; Aoki H; Kunisada T; Yano M; Kuji S; Hirashima Y; Arakawa A; Nishio S; Ushijima K; Ito K; Itani Y; Morishige K
Gynecol Oncol; 2015 May; 137(2):299-305. PubMed ID: 25541259
[TBL] [Abstract] [Full Text] [Related]
